Cargando…
Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients
BACKGROUND: Septic shock is commonly treated in the emergency department (ED) with vasopressors. Prior data have shown that vasopressor administration through a peripheral intravenous line (PIV) is feasible. OBJECTIVES: To characterize vasopressor administration for patients presenting to an academi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973174/ https://www.ncbi.nlm.nih.gov/pubmed/36864853 http://dx.doi.org/10.5005/jp-journals-10071-24243 |
_version_ | 1784898466506342400 |
---|---|
author | Kilian, Scott Surrey, Aaron McCarron, Weston Mueller, Kristen Wessman, Brian Todd |
author_facet | Kilian, Scott Surrey, Aaron McCarron, Weston Mueller, Kristen Wessman, Brian Todd |
author_sort | Kilian, Scott |
collection | PubMed |
description | BACKGROUND: Septic shock is commonly treated in the emergency department (ED) with vasopressors. Prior data have shown that vasopressor administration through a peripheral intravenous line (PIV) is feasible. OBJECTIVES: To characterize vasopressor administration for patients presenting to an academic ED in septic shock. MATERIALS AND METHODS: Retrospective observational cohort study evaluating initial vasopressor administration for septic shock. ED patients from June 2018 to May 2019 were screened. Exclusion criteria included other shock states, hospital transfers, or heart failure history. Patient demographics, vasopressor data, and length of stay (LOS) were collected. Cases were grouped by initiation site: PIV, ED placed central line (ED-CVL), or tunneled port/indwelling central line (Prior-CVL). RESULTS: Of the 136 patients identified, 69 were included. Vasopressors were initiated via PIV in 49%, ED-CVL in 25%, and prior-CVL in 26%. The time to initiation was 214.8 minutes in PIV and 294.7 minutes in ED-CVL (p = 0.240). Norepinephrine predominated all groups. No extravasation or ischemic complications were identified with PIV vasopressor administration. Twenty-eight-day mortality was 20.6% for PIV, 17.6% for ED-CVL, and 61.1% for prior-CVL. Of 28-day survivors, ICU LOS was 4.44 for PIV and 4.86 for ED-CVL (p = 0.687), while vasopressor days were 2.26 for PIV and 3.14 for ED-CVL (p = 0.050). CONCLUSION: Vasopressors are being administered via PIVs for ED septic shock patients. Norepinephrine comprised the majority of initial PIV vasopressor administration. There were no documented episodes of extravasation or ischemia. Further studies should look at the duration of PIV administration with potential avoidance of central venous cannulation altogether in appropriate patients. HOW TO CITE THIS ARTICLE: Kilian S, Surrey A, McCarron W, Mueller K, Wessman BT. Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients. Indian J Crit Care Med 2022;26(7):811–815. |
format | Online Article Text |
id | pubmed-9973174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-99731742023-03-01 Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients Kilian, Scott Surrey, Aaron McCarron, Weston Mueller, Kristen Wessman, Brian Todd Indian J Crit Care Med Original Article BACKGROUND: Septic shock is commonly treated in the emergency department (ED) with vasopressors. Prior data have shown that vasopressor administration through a peripheral intravenous line (PIV) is feasible. OBJECTIVES: To characterize vasopressor administration for patients presenting to an academic ED in septic shock. MATERIALS AND METHODS: Retrospective observational cohort study evaluating initial vasopressor administration for septic shock. ED patients from June 2018 to May 2019 were screened. Exclusion criteria included other shock states, hospital transfers, or heart failure history. Patient demographics, vasopressor data, and length of stay (LOS) were collected. Cases were grouped by initiation site: PIV, ED placed central line (ED-CVL), or tunneled port/indwelling central line (Prior-CVL). RESULTS: Of the 136 patients identified, 69 were included. Vasopressors were initiated via PIV in 49%, ED-CVL in 25%, and prior-CVL in 26%. The time to initiation was 214.8 minutes in PIV and 294.7 minutes in ED-CVL (p = 0.240). Norepinephrine predominated all groups. No extravasation or ischemic complications were identified with PIV vasopressor administration. Twenty-eight-day mortality was 20.6% for PIV, 17.6% for ED-CVL, and 61.1% for prior-CVL. Of 28-day survivors, ICU LOS was 4.44 for PIV and 4.86 for ED-CVL (p = 0.687), while vasopressor days were 2.26 for PIV and 3.14 for ED-CVL (p = 0.050). CONCLUSION: Vasopressors are being administered via PIVs for ED septic shock patients. Norepinephrine comprised the majority of initial PIV vasopressor administration. There were no documented episodes of extravasation or ischemia. Further studies should look at the duration of PIV administration with potential avoidance of central venous cannulation altogether in appropriate patients. HOW TO CITE THIS ARTICLE: Kilian S, Surrey A, McCarron W, Mueller K, Wessman BT. Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients. Indian J Crit Care Med 2022;26(7):811–815. Jaypee Brothers Medical Publishers 2022-07 /pmc/articles/PMC9973174/ /pubmed/36864853 http://dx.doi.org/10.5005/jp-journals-10071-24243 Text en Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2022 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Article Kilian, Scott Surrey, Aaron McCarron, Weston Mueller, Kristen Wessman, Brian Todd Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients |
title | Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients |
title_full | Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients |
title_fullStr | Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients |
title_full_unstemmed | Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients |
title_short | Vasopressor Administration via Peripheral Intravenous Access for Emergency Department Stabilization in Septic Shock Patients |
title_sort | vasopressor administration via peripheral intravenous access for emergency department stabilization in septic shock patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973174/ https://www.ncbi.nlm.nih.gov/pubmed/36864853 http://dx.doi.org/10.5005/jp-journals-10071-24243 |
work_keys_str_mv | AT kilianscott vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients AT surreyaaron vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients AT mccarronweston vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients AT muellerkristen vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients AT wessmanbriantodd vasopressoradministrationviaperipheralintravenousaccessforemergencydepartmentstabilizationinsepticshockpatients |